1-4 of 4
Victor Ghetie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Evaluation of Recombinant, Chimeric, Tetravalent Antihuman CD22 Antibodies

Ruiqi Meng, Joan E. Smallshaw, Laurentiu M. Pop, Michael Yen, Xiaoyun Liu, Lien Le, Maria-Ana Ghetie, Ellen S. Vitetta, Victor Ghetie
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (4): 1274–1281.
https://doi.org/10.1158/1078-0432.CCR-1154-03
Published: 20 February 2004
View article titled, The Evaluation of Recombinant, Chimeric, Tetravalent Antihuman CD22 Antibodies
Open the PDF for The Evaluation of Recombinant, Chimeric, Tetravalent Antihuman CD22 Antibodies in another window
Journal Articles

A Phase I Study with an Anti-CD30 Ricin A-Chain Immunotoxin (Ki-4.dgA) in Patients with Refractory CD30+ Hodgkin’s and Non-Hodgkin’s Lymphoma

Roland Schnell, Oliver Staak, Peter Borchmann, Christine Schwartz, Bärbel Matthey, Hinrich Hansen, John Schindler, Victor Ghetie, Ellen S. Vitetta, Volker Diehl, Andreas Engert
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (6): 1779–1786.
Published: 01 June 2002
View article titled, A Phase I Study with an Anti-CD30 Ricin A-Chain Immunotoxin (Ki-4.dgA) in Patients with Refractory CD30<sup>+</sup> Hodgkin’s and Non-Hodgkin’s Lymphoma
Open the PDF for A Phase I Study with an Anti-CD30 Ricin A-Chain Immunotoxin (Ki-4.dgA) in Patients with Refractory CD30<sup>+</sup> Hodgkin’s and Non-Hodgkin’s Lymphoma in another window
Journal Articles

A Phase I Study of Combination Therapy with Immunotoxins IgG-HD37-Deglycosylated Ricin A Chain (dgA) and IgG-RFB4-dgA (Combotox) in Patients with Refractory CD19(+), CD22(+) B Cell Lymphoma

Richard A. Messmann, Ellen S. Vitetta, Donna Headlee, Adrian M. Senderowicz, William D. Figg, John Schindler, Dennis F. Michiel, Steven Creekmore, Seth M. Steinberg, David Kohler, Elaine S. Jaffe, Maryalice Stetler-Stevenson, Huachun Chen, Victor Ghetie, Edward A. Sausville
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (4): 1302–1313.
Published: 01 April 2000
View article titled, A Phase I Study of Combination Therapy with Immunotoxins IgG-HD37-Deglycosylated Ricin A Chain (dgA) and IgG-RFB4-dgA (Combotox) in Patients with Refractory CD19(+), CD22(+) B Cell Lymphoma
Open the PDF for A Phase I Study of Combination Therapy with Immunotoxins IgG-HD37-Deglycosylated Ricin A Chain (dgA) and IgG-RFB4-dgA (Combotox) in Patients with Refractory CD19(+), CD22(+) B Cell Lymphoma in another window
Journal Articles

Anti-CD19 Antibodies Inhibit the Function of the P-gp Pump in Multidrug-resistant B Lymphoma Cells

Maria-Ana Ghetie, Victor Ghetie, Ellen S. Vitetta
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (12): 3920–3927.
Published: 01 December 1999
View article titled, Anti-CD19 Antibodies Inhibit the Function of the P-gp Pump in Multidrug-resistant B Lymphoma Cells
Open the PDF for Anti-CD19 Antibodies Inhibit the Function of the P-gp Pump in Multidrug-resistant B Lymphoma Cells in another window